Technical Analysis for RDUS - Radius Health, Inc.

Grade Last Price % Change Price Change
grade C 17.51 3.30% 0.56
RDUS closed up 3.3 percent on Friday, January 18, 2019, on 48 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Up Up
See historical RDUS trend table...

Date Alert Name Type % Chg
Jan 18 Wide Bands Range Expansion 0.00%
Jan 18 Up 3 Days in a Row Strength 0.00%
Jan 18 Up 4 Days in a Row Strength 0.00%
Jan 17 Wide Bands Range Expansion 3.30%
Jan 17 Up 3 Days in a Row Strength 3.30%
Jan 15 20 DMA Support Bullish 7.75%
Jan 15 Crossed Above 50 DMA Bullish 7.75%
Jan 14 Fell Below 50 DMA Bearish 11.03%
Jan 14 NR7 Range Contraction 11.03%
Jan 10 Wide Bands Range Expansion 3.36%

Older signals for RDUS ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Radius Health, Inc., a biopharmaceutical company, focuses on developing novel therapeutics for patients with osteoporosis and other serious endocrine-mediated diseases in the United States. Its lead product includes abaloparatide (BA058), a novel synthetic peptide analog of parathyroid hormone-related protein, which is in Phase III clinical development for the treatment of osteoporosis. The company is also developing RAD1901, a selective estrogen receptor down-regulator/degrader for the treatment of breast cancer brain metastases, and vasomotor symptoms; and RAD140, a nonsteroidal selective androgen receptor modulator, which is in preclinical development stage for the treatment of weight loss due to cancer cachexia, muscle frailty and osteoporosis, and breast cancer. It has collaborations and license agreements with Nordic Bioscience Clinical Development VII A/S; 3M; Ipsen Pharma SAS; Eisai; Lonza Group Ltd.; and Charles River Laboratories, Inc. The company was founded in 2003 and is headquartered in Cambridge, Massachusetts.
Is RDUS a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 41.16
52 Week Low 12.81
Average Volume 746,814
200-Day Moving Average 23.0793
50-Day Moving Average 15.9792
20-Day Moving Average 15.9345
10-Day Moving Average 16.734
Average True Range 0.9896
ADX 16.38
+DI 25.8355
-DI 15.4991
Chandelier Exit (Long, 3 ATRs ) 14.9312
Chandelier Exit (Short, 3 ATRs ) 15.7788
Upper Bollinger Band 18.4191
Lower Bollinger Band 13.4499
Percent B (%b) 0.82
BandWidth 31.185164
MACD Line 0.2762
MACD Signal Line 0.1456
MACD Histogram 0.1307
Fundamentals Value
Market Cap 759.66 Million
Num Shares 43.4 Million
EPS -5.19
Price-to-Earnings (P/E) Ratio -3.37
Price-to-Sales 1353.51
Price-to-Book 6.40
PEG Ratio -0.13
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 18.89
Resistance 3 (R3) 18.75 18.16 18.66
Resistance 2 (R2) 18.16 17.81 18.23 18.58
Resistance 1 (R1) 17.83 17.59 18.00 17.97 18.51
Pivot Point 17.24 17.24 17.32 17.31 17.24
Support 1 (S1) 16.91 16.89 17.08 17.05 16.51
Support 2 (S2) 16.32 16.67 16.39 16.44
Support 3 (S3) 15.99 16.32 16.36
Support 4 (S4) 16.13